Literature DB >> 34877997

High discrepancies in the mortality of hospitalized patients with COVID-19 in the two most economically important states in Brazil.

Vitor Barreto Paravidino1,2, Rosely Sichieri1, Danilo Cosme Klein Gomes1, Gulnar Azevedo E Silva1.   

Abstract

OBJECTIVE: The aim of this study was to compare the proportion of deaths among hospitalized cases of COVID-19 in São Paulo and Rio de Janeiro, stratified by private and public services.
METHODS: Hospitalization data for severe acute respiratory syndrome (SARS) were obtained using the SIVEP-Gripe Database. All hospitalized adults who were diagnosed as COVID-19 or unspecified SARS, between January and December 2020, were included in the analysis. Logistic regression models were fitted to evaluate the risk of death between Rio de Janeiro and São Paulo, adjusted for age, sex, and comorbidities.
RESULTS: A total of 388,657 hospital registers for Rio de Janeiro and São Paulo (91,532 and 297,125, respectively) were analyzed. Missing data are frequent in the database and it was greater in Rio de Janeiro, at the state and capital levels. Adjusting for confounders, the odds ratio of dying by COVID-19, comparing the state of Rio de Janeiro with São Paulo, was 2.51 in the private hospitals and 2.29 in the public ones. For the capitals, the scenario is worse. The lethality among hospitalized patients with COVID-19 is at least twice in Rio de Janeiro than São Paulo, both at the states and capitals. The public or private services showed important differences, with odds ratios of 2.74 and 3.46, respectively.
CONCLUSION: It appears that the worst governance in the health sector in Rio de Janeiro, more than lack of resources, explains the excess mortality of hospitalized COVID-19 patients in Rio de Janeiro.

Entities:  

Mesh:

Year:  2021        PMID: 34877997     DOI: 10.1590/1980-549720210056

Source DB:  PubMed          Journal:  Rev Bras Epidemiol        ISSN: 1415-790X


  1 in total

1.  Association between obesity and COVID-19 mortality and length of stay in intensive care unit patients in Brazil: a retrospective cohort study.

Authors:  Vitor Barreto Paravidino; Tatiana Henriques Leite; Mauro Felippe Felix Mediano; Rosely Sichieri; Gulnar Azevedo E Silva; Victor Cravo; Alex Balduino; Emmanuel Salgueiro; Bruno Adler Maccagnan Pinheiro Besen; Rodrigo de Carvalho Moreira; Carlos Eduardo Brandão; Danilo Cosme Klein Gomes; Cinthia Almeida Guimarães Assemany; Pedro Cougo
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.